孕期使用抗抑郁药与新生儿疾病风险
暴露组NICU入住率为13.7%,高于人群的8.2%(调整OR 1.5,95%CI 1.4-1.5),孕晚期暴露组为16.5%对比孕早期暴露组的10.8%(调整OR 1.6,95%CI 1.5-1.8)。暴露后呼吸系统疾病、中枢神经系统疾病和低血糖更常见,孕晚期暴露者持续性肺动脉高压风险更高,但严重疾病的绝对风险较低。
要点
- 孕期SSRI暴露与NICU入住率升高相关(13.7% vs 8.2%,调整OR 1.5)。
- 孕晚期SSRI暴露较孕早期暴露NICU入住率更高(16.5% vs 10.8%,调整OR 1.6)。
- SSRI暴露后呼吸系统疾病、中枢神经系统疾病和低血糖更常见,但严重疾病绝对风险低。
核心结论
- 孕期使用抗抑郁药与新生儿疾病风险增加及NICU入住率升高相关,但严重疾病的绝对风险较低。
研究设计与样本
- 基于瑞典医学出生登记、处方药登记和瑞典新生儿质量登记的回顾性队列研究。
- 比较SSRI暴露与未暴露婴儿,以及孕晚期暴露与仅孕早期暴露婴儿,采用逻辑回归分析。
主要发现
- 母亲使用SSRI后,13.7%的婴儿入住NICU,而人群为8.2%(调整OR 1.5,95%CI 1.4-1.5)。
- 孕晚期治疗后的NICU入住率为16.5%,仅孕早期治疗者为10.8%(调整OR 1.6,95%CI 1.5-1.8)。
- 母亲使用SSRI后,呼吸系统疾病、中枢神经系统疾病和低血糖更常见。
- 与孕早期暴露相比,孕晚期SSRI暴露的婴儿持续性肺动脉高压风险更高(需伤害人数285)。
临床怎么用
- 对孕期使用SSRI的母亲所生新生儿,应关注呼吸系统、中枢神经系统症状及低血糖,并评估NICU入住必要性。
- 孕晚期SSRI暴露的新生儿需警惕持续性肺动脉高压,但严重疾病绝对风险低,临床决策应结合个体情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To estimate the rate of admissions to NICUs, as well as infants' morbidity and neonatal interventions, after exposure to antidepressant drugs in utero. METHODS: Data on pregnancies, deliveries, prescription drug use, and health status of the newborn infants were obtained from the Swedish Medical Birth Register, the Prescribed Drug Register, and the Swedish Neonatal Quality Register. We included 741 040 singletons, born between July 1, 2006, and December 31, 2012. Of the infants, 17 736 (2.4%) had mothers who used selective serotonin reuptake inhibitors (SSRIs) during pregnancy. Infants exposed to an SSRI were compared with nonexposed infants, and infants exposed during late pregnancy were compared with those exposed during early pregnancy only. The results were analyzed with logistic regression analysis. RESULTS: After maternal use of an SSRI, 13.7% of the infants were admitted to the NICU compared with 8.2% in the population (adjusted odds ratio: 1.5 [95% confidence interval: 1.4-1.5]). The admission rate to the NICU after treatment during late pregnancy was 16.5% compared with 10.8% after treatment during early pregnancy only (adjusted odds ratio: 1.6 [95% confidence interval: 1.5-1.8]). Respiratory and central nervous system disorders and hypoglycemia were more common after maternal use of an SSRI. Infants exposed to SSRIs in late pregnancy compared with early pregnancy had a higher risk of persistent pulmonary hypertension (number needed to harm: 285). CONCLUSIONS: Maternal use of antidepressants during pregnancy was associated with increased neonatal morbidity and a higher rate of admissions to the NICU. The absolute risk for severe disease was low, however.
引用
- Nörby U, Forsberg L, Wide K, et al. Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy. Pediatrics. 2016. PMID: 27940758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。